default author photo

Ming Wu

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology

SCHOLARLY PAPERS

2

DOWNLOADS

552

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Advanced Ovarian Yolk Sac Tumor: Upfront Surgery or Neoadjuvant Chemotherapy Followed by Interval Debulking?

Number of pages: 27 Posted: 13 Apr 2023
, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology
Downloads 492 (143,702)

Abstract:

Loading...

Advanced yolk sac tumor, neoadjuvant chemotherapy, primary surgery, cytoreduction, survival

2.

Multigene Germline Testing for Epithelial Ovarian Cancer in China

Number of pages: 30 Posted: 17 Apr 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Peking University - Peking University Cancer Hospital & Institute, Shandong Academy of Medical Sciences, Peking University, NanKai University - Tianjin Central Hospital of Obstetrics and Gynecology, Qingdao University, China Medical University, Huazhong University of Science and Technology - Department of Obstetrics and Gynecology, Zhejiang Cancer Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Obstetrics and Gynecology
Downloads 60 (1,000,027)

Abstract:

Loading...

Germline BRCA 1/2 mutations, Epithelial ovarian cancer (EOC), Cancer-predisposing genes (CPGs), Homologous recombination (HR) genes, Overall survival (OS) and progression-free survival (PFS)